Athira Pharma: Fosgonimeton May Outperform Lecanemab In Alzheimer's
Seeking Alpha,
Follow Summary Athira Pharma’s stock has sold off some months ago on its Alzheimer’s drug candidate Fosgonimeton not meeting a…
Follow Summary Athira Pharma’s stock has sold off some months ago on its Alzheimer’s drug candidate Fosgonimeton not meeting a…
Late last week came this report in Science about doctored images in a series of very influential papers on amyloid and Alzheimer…
Jason Mast Editor Before MRIs or CT scans, 18th-century anatomist Paolo Mascagni injected his cadavers with mercury.
Summary Alzheon received funding from the National Institutes of Health to conduct a phase 3 clinical trial for its drug ALZ-801…